tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Galmed reports Q3 EPS (33c) vs. ($2.31) last year
PremiumThe FlyGalmed reports Q3 EPS (33c) vs. ($2.31) last year
8d ago
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
Premium
The Fly
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
16d ago
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
Premium
Company Announcements
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
16d ago
Galmed Pharmaceuticals Schedules Annual General Meeting for October 2025
PremiumCompany AnnouncementsGalmed Pharmaceuticals Schedules Annual General Meeting for October 2025
3M ago
Galmed Pharmaceuticals Announces Q2 2025 Financial Results and Strategic Updates
Premium
Company Announcements
Galmed Pharmaceuticals Announces Q2 2025 Financial Results and Strategic Updates
3M ago
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement
Premium
Company Announcements
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement
3M ago
Galmed Pharmaceuticals to Hold Special Meeting on Share Capital Increase
PremiumCompany AnnouncementsGalmed Pharmaceuticals to Hold Special Meeting on Share Capital Increase
4M ago
Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential
Premium
Company Announcements
Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential
6M ago
Galmed Pharmaceuticals Reports Q1 2025 Financial Results and Advances in Oncology
Premium
Company Announcements
Galmed Pharmaceuticals Reports Q1 2025 Financial Results and Advances in Oncology
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100